chevron_leftBack
As of 21 June 2026, Eusol Biotech Co.,Ltd. has a market cap of $8.49M USD, ranking #42149 globally and #2332 in Taiwan.
It ranks #3731 in the Healthcare sector, and #734 in the Biotechnology industry.
Key Stats
Market Cap
$8.49MUSD
268.52M TWD
Enterprise Value
-$664.68KUSD
-21.03M TWD
Revenue (TTM)
$65.68KUSD
2.08M TWD
EBITDA (TTM)
-$1.46MUSD
-46.28M TWD
Net Income (TTM)
-$1.28MUSD
-40.42M TWD
PS Ratio
129.3
PB Ratio
0.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Wan-Ya Zhang
open_in_new
Founded
1994
Website
eusol-biotech.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | -18% | -69% | -67% | -75% | -68% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
6652
雅祥生技醫藥股份有限公司 Ordinary Shares
ISIN: TW0006652001
Shares Out.:
Shares Outstanding:
137.0M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
1.96 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Eusol Biotech Co.,Ltd.
Eusol Biotech Co.,Ltd. focuses on research and development of new drugs for the treatment of nerve injuries in Hong Kong and Taiwan. The company’s pipeline includes ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) for spinal cord injury that is in phase 1, 2, and 3 clinical trials, and SM-1, a 3-in-1 combination sleeping aid. It also offers small molecule drugs including EPS221, a selective serotonin reuptake inhibitor; EPS222, a calcium channel blocker for cardiovascular disease; EPS251, a drug for rheumatology/anti-inflammation; and EA2501, a drug for anticoagulation. The company was founded in 1994 and is headquartered in Taipei, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6919
|
$5.46B
64K%
172.76B TWD
|
-
|
|
TWSE: 6949
|
$1.61B
19K%
50.93B TWD
|
-
|
|
TPEX: 6696
|
$1.08B
13K%
34.04B TWD
|
-
|
|
TWSE: 7827
|
$726.25M
8K%
22.97B TWD
|
-
|
|
|
TPEX: 7827
|
$600.25M
7K%
18.98B TWD
|
-
|
|
TPEX: 06891
|
$571.26M
7K%
18.06B TWD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
2M%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
2M%
|
19.0
|
|
EBR: ARGX
|
$47.43B
558K%
41.39B EUR
|
39.9
|
|
KRX: 207940
|
$44.23B
521K%
68.19T KRW
|
35.5
|
|
ASX: CSL
|
$42.27B
498K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$41.88B
493K%
33.71B CHF
|
37.2
|
chevron_leftBack